Xsolla Set to Launch the Xsolla StarNest Academy and Incubator Program in Baku
9.12.2024 10:00:00 CET | Business Wire | Press release
Collaboration in Azerbaijan Aims to Build a Thriving Game Development Ecosystem and Empower Local Talent with New Programs Launching in 2025
Xsolla, a global video game commerce company, has announced a strategic partnership with StarNest and Azerbaijan’s Innovation and Digital Development Agency (IDDA) to establish the Xsolla StarNest Academy and Incubator Program. This transformative collaboration was unveiled at the region's largest gaming festival, Gamesummit Winter Edition 2024, in Baku, Azerbaijan.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241209823866/en/
(Graphic: Xsolla)
Gamesummit Winter Edition 2024 spotlighted the growth of the gaming industry in Azerbaijan, featuring discussions on trends, global best practices, and presentations of locally developed games. At the festival, IDDA and Xsolla revealed plans to empower local developers, game designers, and studios with cutting-edge training, incubation and accelerator programs, and access to financial and technological resources. This partnership will redefine Azerbaijan's role in the global gaming industry while fostering local talent and innovation.
“This collaboration opens up extensive opportunities for implementing joint projects that will drive the development of Azerbaijan's gaming sector,” said Yevgeniya Bikmurzina, Head of IDDA's Innovation Ecosystem Department. “Azerbaijani game studios will have access to the tools and resources needed to make a mark in the global market.”
“This partnership represents a significant milestone for Xsolla as we collaborate with Azerbaijani leaders to unlock the region’s potential,” said Rytis Joseph Jan, SVP of Global Strategic Partnerships at Xsolla. “By combining our global expertise with the visionary leadership of our partners, we aim to empower the next generation of talent in Azerbaijan and drive meaningful innovation with global impact.”
Xsolla Incubator & Accelerator in Azerbaijan
The Xsolla Incubator and Accelerator will support Azerbaijan's game development community by providing tools, mentorship, and resources to turn ideas into successful projects. The Incubator will help early-stage developers refine concepts, gain technical expertise, and collaborate with international experts. The Accelerator will assist established studios in scaling their projects, offering access to funding, mentorship, and global industry connections. These programs aim to position Azerbaijan as a key player in the gaming industry, creating opportunities for local talent to succeed globally.
Xsolla StarNest Academy
The Xsolla StarNest Academy will provide 90 young individuals with specialized training in game development. Additionally, an incubation program will launch in 2025 to support local game studios, offering mentorship from international experts, access to financial resources, and opportunities to showcase games globally.
StarNest, an Azerbaijani telecommunications company, will lead efforts to secure a dedicated facility for the Academy, ensuring an environment conducive to growth and learning. IDDA will offer strategic oversight to align the initiative with Azerbaijan’s national goals for digital transformation.
Regional Headquarters
Xsolla is also exploring options to establish its regional headquarters for Central Asia in Baku to further support its commitment to the community and game developers in the region. Not only will it serve as a regional hub, but also a technology center for the leading edge development and support of its industry leading solutions.
With the Xsolla StarNest partnership this marks a new chapter for Azerbaijan’s gaming sector reflecting the shared vision to position the country as a regional game development and digital innovation leader.
This groundbreaking collaboration sets the stage for Azerbaijan to become a hub for gaming innovation and talent development. For more information, please visit: xsolla.blog/azerbaijan
About Xsolla
Xsolla is a global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch, and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in London, Berlin, Seoul, Beijing, Kuala Lumpur, Raleigh, Tokyo, Montreal, and cities around the world.
For more information, visit xsolla.com
About the Innovation and Digital Development Agency (IDDA)
IDDA is an Azerbaijani government agency specializing in digital diplomacy and analytics, offering research, training, and consultancy to enhance the digital presence of institutions. It plays a pivotal role in shaping modern diplomatic strategies through digital tools and data analysis.
For more information, visit idda.az
About StarNest
StarNest is a leading Azerbaijani telecommunications company providing internet and networking solutions, including broadband services, corporate connectivity, and IT infrastructure support. StarNest is dedicated to enabling technological growth and digital transformation across Azerbaijan.
For more information, visit starnest.io
About GameSummit
GameSummit is a prominent organization in Azerbaijan focused on the development of the gaming industry. Through events like Gamesummit Winter and Summer Editions, it creates opportunities for local game studios, promotes innovation, and raises awareness about career prospects in gaming and esports.
For more information, visit gamesummit.ai
View source version on businesswire.com: https://www.businesswire.com/news/home/20241209823866/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom